Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells

[1]  R. Baric,et al.  Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection , 2019, mBio.

[2]  I. König,et al.  Rhinovirus infections change DNA methylation and mRNA expression in children with asthma , 2018, PloS one.

[3]  S. Johnston,et al.  Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations , 2018, Nature Communications.

[4]  M. Kraft,et al.  Comparison of paired human nasal and bronchial airway epithelial cell responses to rhinovirus infection and IL-13 treatment , 2018, Clinical and Translational Medicine.

[5]  Ben Smith.  Principles of virology , 2017, Veterinary Record.

[6]  K. Shirato,et al.  Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry , 2016, Journal of Virology.

[7]  R. Nagatomi,et al.  Increased rhinovirus replication in nasal mucosa cells in allergic subjects is associated with increased ICAM‐1 levels and endosomal acidification and is inhibited by L‐carbocisteine , 2016, Immunity, inflammation and disease.

[8]  S. Ōmura,et al.  The non-antibiotic macrolide EM900 inhibits rhinovirus infection and cytokine production in human airway epithelial cells , 2015, Physiological reports.

[9]  P. Barnes.  Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. , 2015, The Journal of allergy and clinical immunology.

[10]  R. Nagatomi,et al.  Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells. , 2014, Respiratory investigation.

[11]  H. Kubo,et al.  Tulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells , 2013, Physiological reports.

[12]  D. Proud,et al.  Modulation of transcriptional responses by poly(I:C) and human rhinovirus: effect of long-acting β₂-adrenoceptor agonists. , 2013, European journal of pharmacology.

[13]  M. Habjan,et al.  TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium , 2013, Journal of Virology.

[14]  T. Voshaar,et al.  Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium* , 2013, Journal of drug assessment.

[15]  C. Hirokawa,et al.  Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-2008 depend on the S1 region sequence of the spike protein. , 2012, The Journal of general virology.

[16]  R. Nagatomi,et al.  Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells , 2012, European Respiratory Journal.

[17]  A. Murphy,et al.  Efficient differentiation and function of human macrophages in humanized CSF-1 mice. , 2011, Blood.

[18]  D. Longo,et al.  Antigen-Independent IFN-γ Production by Human Naïve CD4+ T Cells Activated by IL-12 Plus IL-18 , 2011, PloS one.

[19]  H. Boushey,et al.  Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection. , 2010, American journal of respiratory cell and molecular biology.

[20]  S. Johnston,et al.  Co-ordinated Role of TLR3, RIG-I and MDA5 in the Innate Response to Rhinovirus in Bronchial Epithelium , 2010, PLoS pathogens.

[21]  S. J. Flint.  principles-of-virology , 2008 .

[22]  F. Taguchi,et al.  Protease-Mediated Entry via the Endosome of Human Coronavirus 229E , 2008, Journal of Virology.

[23]  M. Profita,et al.  Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. , 2008, European journal of pharmacology.

[24]  J. Oosterheert,et al.  Frequent Detection of Human Coronaviruses in Clinical Specimens from Patients with Respiratory Tract Infection by Use of a Novel Real-Time Reverse-Transcriptase Polymerase Chain Reaction , 2004, The Journal of infectious diseases.

[25]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[26]  Xuebiao Yao,et al.  Cell biology of acid secretion by the parietal cell. , 2003, Annual review of physiology.

[27]  A. Caplan,et al.  Cytokines and glucocorticoids differentially regulate APN/CD13 and DPPIV/CD26 enzyme activities in cultured human dermal fibroblasts , 2003, Archives of Dermatological Research.

[28]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[29]  S. Mildenberger,et al.  NHE3 serves as a molecular tool for cAMP-mediated regulation of receptor-mediated endocytosis. , 2002, American journal of physiology. Renal physiology.

[30]  Hidetada Sasaki,et al.  Acid stimulation reduces bactericidal activity of surface liquid in cultured human airway epithelial cells. , 2002, American journal of respiratory cell and molecular biology.

[31]  T. Seemungal,et al.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[32]  K. Holmes,et al.  Molecular Determinants of Species Specificity in the Coronavirus Receptor Aminopeptidase N (CD13): Influence of N-Linked Glycosylation , 2001, Journal of Virology.

[33]  N. Delamere,et al.  H+-ATPase-Mediated Cytoplasmic pH-Responses Associated with Elevation of Cytoplasmic Calcium in Cultured Rabbit Nonpigmented Ciliary Epithelium , 2001, The Journal of Membrane Biology.

[34]  R. Atmar,et al.  Spectrum of Clinical Illness in Hospitalized Patients with “Common Cold” Virus Infections , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  H. Lemoine,et al.  Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase. , 1999, The Journal of pharmacology and experimental therapeutics.

[36]  R. Rao,et al.  Novel Localization of a Na+/H+ Exchanger in a Late Endosomal Compartment of Yeast , 1998, The Journal of Biological Chemistry.

[37]  J. Godbillon,et al.  Automated and sensitive method for the determination of formoterol in human plasma by high-performance liquid chromatography and electrochemical detection. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[38]  B. Aggarwal,et al.  Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Weiliang Tang,et al.  Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. , 1996, The Journal of clinical investigation.

[40]  K. Nicholson,et al.  Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.

[41]  A. Look,et al.  Human aminopeptidase N is a receptor for human coronavirus 229E , 1992, Nature.

[42]  M. Yamaya,et al.  Differentiated structure and function of cultures from human tracheal epithelium. , 1992, The American journal of physiology.

[43]  A. Mcclelland,et al.  The major human rhinovirus receptor is ICAM-1 , 1989, Cell.

[44]  K. Altendorf,et al.  Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. Hansen,et al.  Biosynthesis of intestinal microvillar proteins. Forskolin reduces surface expression of aminopeptidase N. , 1987, European journal of cell biology.

[46]  I Mellman,et al.  Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.

[47]  J. Fitzgerald,et al.  The Pharmacology of a β2‐Selective Adrenoceptor Antagonist (ICI 118,551) , 1983 .